MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0049987
Prism Life Sciences Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹36.89 Cr
▼ 11% YoY
Net profit · FY 2025
₹37.65 Lakh
Net margin 1%
EBITDA · FY 2025
₹6.2 Cr
EBITDA margin 16.8%
Authorised capital
₹9 Cr
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹19.73 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
248
Provident fund records
About Prism Life Sciences Limited
Data last updated:
Prism Life Sciences Limited is a public limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 September 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2002PLC137217. Its GSTIN is 27AACCP8078L1ZS (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹10 Lakh. It is led by director Neeta Narayan Shirke.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1003/1004 10th Floor A – Wingthe Great Eastern Summit Sector 15 C B D Belapur, Thane, Maharashtra, India – 400614.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.89 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹37.65 Lakh (net margin 1%) and EBITDA of ₹6.2 Cr (EBITDA margin 16.8%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.
The company has about 248 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹19.73 Cr on record. Court records list 28 cases involving the company, including 16 filed by the company and 12 filed against it; 10 cases are pending.
Prism Life Sciences Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0049987). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website prismile.com.
Company details
CIN U24230MH2002PLC137217
Registration Number 137217
Incorporation Date 16 September 2002
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0049987
CIN history
Prism Life Sciences has one previous CIN (Corporate Identification Number): L24230MH2002PLC137217. The current CIN is U24230MH2002PLC137217, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2002PLC137217 | Current |
| L24230MH2002PLC137217 | Previous |
Recognitions & Rankings of Prism Life Sciences
Contact details
Prism Life Sciences Limited's registered office is in Thane, Maharashtra. Its website is prismile.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1003/1004 10th Floor A – Wingthe Great Eastern Summit Sector 15 C B D Belapur, Thane, Maharashtra, India – 400614
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Prism Life Sciences Limited, buy the company report.
Comprehensive company report
Prism Life Sciences Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Prism Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Prism Life Sciences Limited, buy the company report.
Financials of Prism Life Sciences Limited
FY 2024 filings availablePrism Life Sciences Limited reported revenue of ₹36.89 Cr (down 11% YoY) for FY 2025.
Revenue · FY 2025
₹36.89 Cr ▼ 11%
Net profit · FY 2025
₹37.65 Lakh margin 1%
EBITDA · FY 2025
₹6.2 Cr margin 16.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 6%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▲ 7%
5 years · compounded
▲ 14%
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 11% fall in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.2 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹37.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.8% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prism Life Sciences Limited, buy the company report.
Board of directors and KMP of Prism Life Sciences Limited
Prism Life Sciences Limited currently reports 1 director and 2 key managerial personnel. 8 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shibu Chandrasekhar Kurup Also directs: Jaywin Remedies Private Limited | Ceo | 03 Aug 2024 | 2 Years 2 Months | Current |
| Ajay Manmohan Joshi Also directs: Jaywin Remedies Private Limited | Cfo | 03 Aug 2024 | 2 Years 2 Months | Current |
| Neeta Narayan Shirke Also directs: Jaywin Remedies Private Limited | Director | 03 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Prism Life Sciences Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alvio Pharmaceuticals Private Limited | ₹37.1 Cr (FY 2025) | 7.0% | Sarkhej, Gujarat, India | |||
| Shifa Remedies Private Limited | ₹37.06 Cr (FY 2025) | 6.0% | New Delhi, Delhi, India | |||
| Acies Pharmaceutical Private Limited | ₹37.03 Cr (FY 2025) | 68.0% | Dehradun, Uttarakhand, India | |||
| Prism Life Sciences Limitedthis company | ₹36.89 Cr (FY 2025) | ₹37.65 Lakh | 1% | -11.0% | 248 | Thane, Maharashtra, India |
| Quality Bestochem Formulations Private Limited | ₹36.71 Cr (FY 2024) | 18.0% | Delhi, India |
To see the full peer comparison of Prism Life Sciences Limited, buy the company report.
Auditor
Prism Life Sciences Limited is audited by SUNDARAMSESHAN for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNDARAMSESHAN | FY 2024 | 107966 |
Shareholding
The shareholding of Prism Life Sciences Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Prism Life Sciences Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
₹19.73 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jul 2023 | 100757630 | Others | ₹2 Cr | Open | |
| 26 Sep 2019 | 100296404 | Axis Bank Limited | ₹6.75 Cr | Satisfied | |
| 29 Oct 2008 | 10269861 | Idbi Bank Limited | ₹4.74 Cr | Satisfied | |
| 31 Jul 2008 | 10251922 | Idbi Bank Limited | ₹4.74 Cr | Satisfied | |
| 30 May 2007 | 10083159 | Hdfc Bank Limited | ₹3 Cr | Satisfied |
To see the full charge records of Prism Life Sciences Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Prism Life Sciences Limited has 28 court cases on record: 16 filed by Prism Life Sciences, 12 filed against it. 10 cases are pending and 18 are disposed.
Total cases
28
Filed by the company
16
Filed against the company
12
Pending
10
Disposed
18
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 24 | 10 | 10 |
| High courts | 4 | 2 | 0 |
Cases on record (5 of 28)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Commercial suit | Filed against the company by Samchem India Private Limited | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Group Pharmaceuticals Ltd Through Authorized Representative Pandurang G Gardi | Disposed |
| District court, Thane, Maharashtra | Court case (Cri.Rev.App.) | Filed by the company against an individual | Pending |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by an individual | Pending |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Appln.PGA) | Filed against the company by an individual | Pending |
To see the full case history of Prism Life Sciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prism Life Sciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Prism Life Sciences has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Jaywin Remedies Private Limited | U24231GJ1988PTC010605 |
To see the full group structure of Prism Life Sciences Limited, buy the company report.
Employees & EPFO
Prism Life Sciences Limited has a workforce of 248 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
Employee count
248
Active EPFO establishments
1
GST
Prism Life Sciences has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCP8078L1ZS | Maharashtra | Active | 01 Jul 2017 |
| 24AACCP8078L2ZX | Gujarat | Active | 14 Mar 2018 |
To see the full GST registrations and return filing status of Prism Life Sciences Limited, buy the company report.
Recent activity
Prism Life Sciences Limited has 11 board changes on record since 2007: 3 appointments and 8 cessations. The latest: Vivek Sheel Batra ceased to be Director on 30 Apr 2025.
Ceased
Vivek Sheel Batra ceased to be Director.
AGM
Prism Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Neeta Narayan Shirke ceased to be Additional Director.
Appointed
Ajay Manmohan Joshi was appointed as CFO.
Appointed
Neeta Narayan Shirke was appointed as Director.
Appointed
Shibu Chandrasekhar Kurup was appointed as CEO.
Ceased
Shibu Chandrasekhar Kurup ceased to be Director.
Filing
Prism Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100757630 was registered on 30 Jul 2023.
Ceased
Ranganathan Nagarajan ceased to be Director.
Charges
A charge registered on 29 Oct 2008 via Charge ID 10269861 with Idbi Bank Limited was fully satisfied on 08 Jun 2020.
Charges
A charge registered on 31 Jul 2008 via Charge ID 10251922 with Idbi Bank Limited was fully satisfied on 08 Jun 2020.
17 earlier events are in the company report.
Frequently asked questions
Prism Life Sciences is an active public limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 September 2002 (24+ years old) and is registered under CIN U24230MH2002PLC137217.
Prism Life Sciences has 3 current directors and KMP:
- Neeta Narayan Shirke - Director
- Shibu Chandrasekhar Kurup - Ceo
- Ajay Manmohan Joshi - Cfo
The latest financial statements of Prism Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Prism Life Sciences is 27AACCP8078L1ZS, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 24AACCP8078L2ZX (Gujarat).
The CIN (Corporate Identification Number) of Prism Life Sciences is U24230MH2002PLC137217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prism Life Sciences has 28 court cases on record: 16 filed by the company and 12 filed against it. 10 are pending. Most are in the district courts.
Prism Life Sciences was incorporated on 16 September 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Prism Life Sciences by revenue are Alvio Pharmaceuticals Private Limited, Shifa Remedies Private Limited, Acies Pharmaceutical Private Limited, Quality Bestochem Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Vivek Sheel Batra ceased to be Director on 30 Apr 2025. Neeta Narayan Shirke ceased to be Additional Director on 05 Aug 2024. Ajay Manmohan Joshi was appointed as CFO on 03 Aug 2024. Prism Life Sciences has 11 board changes on record in total.
Yes, Prism Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0049987).
Prism Life Sciences can be reached through the website prismile.com. Its registered office is in Thane, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages